Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Sensex Opens Higher; Realty Stocks Lead
Thu, 7 Nov 09:30 am | Rini Mehta, TM Team

Asian share markets are mixed today. The Shanghai Composite is flat while the Hang Seng is down 0.3%. The Nikkei 225 is trading flat. US stocks ended mixed yesterday, with the Dow little changed, as Wall Street digested decreased US labor productivity in the third quarter and a speech of Chicago Federal Reserve President Charles Evans.

Back home, India share markets opened higher. The BSE Sensex is trading up by 137 points while the NSE Nifty is trading up by 32 points. The BSE Mid Cap index and BSE Small Cap index opened up by 0.6% and 0.5% respectively.

Sectoral indices have opened the day on a mixed note with realty stocks and consumer durables stocks witnessing maximum buying interest. Automobiles stocks and metal stocks are trading in red.

The rupee is currently trading at 71.10 against the US$.

--- Advertisement ---
The Biggest Opportunity Available Right Now

Today, coronavirus crisis has created a lot of fear and uncertainty.

But amid this fear and chaos... there is one thing which is certain.

As soon as the fears of coronavirus abate... there would be a massive rally in the stock markets.

You won't be able to grab the stocks... which are available at a throw away prices today.

This is the time to start loading up on fundamentally strong stocks.

Because the returns that one could potentially make from these prices could be mind-boggling.

Potentially Rs 1 crore or more in the long run.

And we've already shortlisted one stock having that potential.

Click here to know more about this stock

Speaking of the Sensex touching record high, how expensive is the Sensex at current levels? What has the trend been in recent years?

It would be interesting to see how the valuation of the index has moved over the last five years.

The chart below maps the price to earnings ratio of the Sensex from October 2014 to now.

How Pricey Is the Sensex Now?

Here's what Ankit Shah wrote about this in a recent edition of The 5 Minute WrapUp...

  • It is worth noting that the Sensex has gained 44% over the last five years, compounding at an annual rate of 7.6% (excluding dividends).

    Not quite impressive.

    During the same period, the Sensex price to earnings ratio has mostly been in a rising trend, except some intermittent declines.

    Between October 2014 and now, the gain in the Sensex price to earnings ratio is 42%. That means that the gains in the index have mostly come from expansion in the valuation multiple, and just meagerly from increases in earnings.

So, before taking the current market bullishness for granted, do weigh in the fact that the Sensex is quite expensively priced.

Also, amid the mood swings of Mr. Market witnessed lately, Tanushree Banerjee in the video below talks about the Rebirth of India phenomenon and how 3 specific trends are racing ahead even in these gloomy times.

--- Advertisement ---
This Lockdown Become a Pro Investor...FREE

We have great news for you.

For the duration of the lockdown – we are giving everybody completely free access to our two most popular learning courses.

Equitymaster's Secrets– an online course that will reveal the complete process behind our own stock–picking strategy.

DeriVantage – an online course that will teach you to trade derivatives – and develop your own trading strategy to create short–term and long–term wealth.

This is a one–time opportunity...with no strings attached. Access is absolutely free – no credit card required.

Just click below and we will instantly activate your free access to either or both courses.

Click Here for Free Access: Equitymaster's Secrets | DeriVantage

Tune in to find out more...

In the news from the economy. Fitch Solutions on Wednesday raised India's fiscal deficit forecast to 3.6% of the GDP for this fiscal year, from 3.4% previously, due to weak revenue collections resulting from sluggish economic growth and government's sweeping corporate tax rate cut.

Fitch said it was revising the fiscal deficit forecast as revenue collection is likely to fall far short of the projections in the FY20 Union Budget due to weak goods and services tax (GST) and corporate income tax collections.

The government on September 20, had announced that it would be slashing corporate income taxes for domestic companies to 22% from 30% previously.

This would bring effective corporate tax rate, including all additional levies, to about 25.2%, for companies which are not receiving any incentives or exemptions.

New manufacturing companies formed after October 1, will enjoy a 15% (effective rate of 17%) corporate income tax rate, versus 25% previously.

The move is estimated to result in Rs 1.45 trillion in revenue loss for the government during FY20.

Corporate tax accounts for 28% of total receipts. Therefore, the sharp reduction in tax rates will drag heavily on revenue collection.

Separately, Fitch expects weak private consumption growth to weigh on GST collection and this is already being reflected in the growing shortfall in GST collections thus far in FY20.

Besides, private consumption growth more than halved to 3.1% year-on-year in Q1 of FY20 from 7.2% year-on-year in Q4 of FY19 largely due to the collapse of a dominant Non-Bank Finance Company (NBFC) in the industry, the Infrastructure Leasing & Financial Services Ltd (IL&FS), in September 2018, it added.

Moving on to the news from the pharma sector. As per an article in a leading financial daily, the United States Food and Drug Administration (USFDA) has issued four observations each for Aurobindo Pharma's two units in Hyderabad after inspecting the sites in October.

The USFDA inspected active pharmaceutical ingredients (API) manufacturing facility (Unit V) at Pashamylaram and API manufacturing facility (Unit VIII) at Gaddapotharam in Hyderabad between 21 October 2019 and 28 October 2019.

Reportedly, these observations are related to procedural improvements and none of the observations are related to data integrity.

The company said it would be responding to USFDA as per the prescribed timelines.

With respect to Unit IV, formulation manufacturing facility at Pashamylaram, the inspection is in progress, it added.

Notably, the stock has fallen more than 40% in the last one year.

Aurobindo Pharma share price opened the day down by 1.2%.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Sensex Opens Higher; Realty Stocks Lead". Click here!


Stock Market Updates

LUPIN Surges by 10%; BSE HEALTHCARE Index Up 4.9% (Today's Market)

Apr 9, 2020 09:53 AM

LUPIN share price has surged by 10% and its current market price is Rs 776. The BSE HEALTHCARE is up by 4.9%. The top gainers in the BSE HEALTHCARE Index are LUPIN (up 10.0%) and ABBOTT INDIA (up 5.3%). The top losers are DR. LAL PATHLABS LTD (down 0.5%) and THYROCARE TECHNOLOGIES (down 3.6%).

DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Up 4.9% (Today's Market)

Apr 9, 2020 09:53 AM

DIVIS LABORATORIES share price has hit an all time high at Rs 2,315 (up 6.1%). The BSE HEALTHCARE Index is up by 4.9%. Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 6.1%) and ABBOTT INDIA (up 5.3%). The top losers include DR. LAL PATHLABS LTD (down 0.5%) and THYROCARE TECHNOLOGIES (down 3.6%).

UJJIVAN FINANCIAL SERVICES Surges by 12%; BSE 500 Index Up 3.0% (Today's Market)

Apr 9, 2020 09:53 AM

UJJIVAN FINANCIAL SERVICES share price has surged by 12% and its current market price is Rs 162. The BSE 500 is up by 3.0%. The top gainers in the BSE 500 Index are UJJIVAN FINANCIAL SERVICES (up 11.9%) and VINATI ORGANICS (up 13.3%). The top losers are PHOENIX MILL (down 0.1%) and CITY UNION BANK (down 0.3%).

SCHNEIDER ELECTRIC INFRA Surges by 6%; BSE CAPITAL GOODS Index Up 2.1% (Today's Market)

Apr 9, 2020 09:53 AM

SCHNEIDER ELECTRIC INFRA share price has surged by 6% and its current market price is Rs 72. The BSE CAPITAL GOODS is up by 2.1%. The top gainers in the BSE CAPITAL GOODS Index are SCHNEIDER ELECTRIC INFRA (up 5.6%) and HEG (up 10.0%). The top losers are CARBORUNDUM UNIVERSAL (down 0.8%) and SCHAEFFLER INDIA LTD (down 2.2%).

MARUTI SUZUKI Surges by 7%; BSE AUTO Index Up 4.8% (Today's Market)

Apr 9, 2020 09:53 AM

MARUTI SUZUKI share price has surged by 7% and its current market price is Rs 5,010. The BSE AUTO is up by 4.8%. The top gainers in the BSE AUTO Index are MARUTI SUZUKI (up 6.6%) and HERO MOTOCORP (up 5.5%). The top losers [TOPLOSERS].

Indian Indices End Lower, LIC IPO, Stocks in Focus, and Top Cues to Track Today (Today's Market)

Apr 9, 2020 Pre-Open

Top cues to track in today's stock market session.

View More Indian Share Market News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

A Safe Stock to Lockdown Now(The 5 Minute Wrapup)

Apr 2, 2020

The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

How to Identify a Market Rebound(Fast Profits Daily)

Mar 27, 2020

This very useful indicator can spot a market bottom.


How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms


Apr 9, 2020 10:41 AM